These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 27711210)

  • 1. Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice.
    Hosono K; Isonaka R; Kawakami T; Narumiya S; Majima M
    PLoS One; 2016; 11(10):e0162532. PubMed ID: 27711210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation.
    Hosono K; Suzuki T; Tamaki H; Sakagami H; Hayashi I; Narumiya S; Alitalo K; Majima M
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1049-58. PubMed ID: 21311040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis.
    Kubo H; Hosono K; Suzuki T; Ogawa Y; Kato H; Kamata H; Ito Y; Amano H; Kato T; Sakagami H; Hayashi I; Sugimoto Y; Narumiya S; Watanabe M; Majima M
    Biomed Pharmacother; 2010 Feb; 64(2):101-6. PubMed ID: 20034758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
    Majumder M; Xin X; Liu L; Girish GV; Lala PK
    Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.
    Xin X; Majumder M; Girish GV; Mohindra V; Maruyama T; Lala PK
    Lab Invest; 2012 Aug; 92(8):1115-28. PubMed ID: 22641101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.
    Su JL; Shih JY; Yen ML; Jeng YM; Chang CC; Hsieh CY; Wei LH; Yang PC; Kuo ML
    Cancer Res; 2004 Jan; 64(2):554-64. PubMed ID: 14744769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Role of mPGES-1 (Microsomal Prostaglandin E Synthase-1)-Derived PGE
    Hao H; Hu S; Wan Q; Xu C; Chen H; Zhu L; Xu Z; Meng J; Breyer RM; Li N; Liu DP; FitzGerald GA; Wang M
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1115-1124. PubMed ID: 29599139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E receptor EP4 stimulates lymphangiogenesis to promote mucosal healing during DSS-induced colitis.
    Hosono K; Kojo K; Narumiya S; Majima M; Ito Y
    Biomed Pharmacother; 2020 Aug; 128():110264. PubMed ID: 32447215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension.
    Zhang MZ; Yao B; Wang Y; Yang S; Wang S; Fan X; Harris RC
    J Clin Invest; 2015 Nov; 125(11):4281-94. PubMed ID: 26485285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells.
    Nandi P; Girish GV; Majumder M; Xin X; Tutunea-Fatan E; Lala PK
    BMC Cancer; 2017 Jan; 17(1):11. PubMed ID: 28056899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment of a prostaglandin E receptor subtype, EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis.
    Kamoshita E; Ikeda Y; Fujita M; Amano H; Oikawa A; Suzuki T; Ogawa Y; Yamashina S; Azuma S; Narumiya S; Unno N; Majima M
    Am J Pathol; 2006 Oct; 169(4):1458-72. PubMed ID: 17003499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Endothelial Growth Factor Receptor Type 1 Signaling Prevents Delayed Wound Healing in Diabetes by Attenuating the Production of IL-1β by Recruited Macrophages.
    Okizaki S; Ito Y; Hosono K; Oba K; Ohkubo H; Kojo K; Nishizawa N; Shibuya M; Shichiri M; Majima M
    Am J Pathol; 2016 Jun; 186(6):1481-98. PubMed ID: 27085138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors.
    Hatazawa R; Tanaka A; Tanigami M; Amagase K; Kato S; Ashida Y; Takeuchi K
    Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G788-97. PubMed ID: 17673547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems.
    Katoh H; Hosono K; Ito Y; Suzuki T; Ogawa Y; Kubo H; Kamata H; Mishima T; Tamaki H; Sakagami H; Sugimoto Y; Narumiya S; Watanabe M; Majima M
    Am J Pathol; 2010 Mar; 176(3):1469-83. PubMed ID: 20110411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
    Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
    Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of adipocyte cyclooxygenase-2 and prostaglandin E2-prostaglandin E receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance.
    Chan PC; Hsiao FC; Chang HM; Wabitsch M; Hsieh PS
    FASEB J; 2016 Jun; 30(6):2282-97. PubMed ID: 26932930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
    Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
    J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of the proangiogenic prostaglandin E receptor EP3 and reduced angiogenesis in a mouse model of diabetes mellitus.
    Oba K; Hosono K; Amano H; Okizaki S; Ito Y; Shichiri M; Majima M
    Biomed Pharmacother; 2014 Oct; 68(8):1125-33. PubMed ID: 25465154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing effects of prostaglandin E
    Carboneau BA; Allan JA; Townsend SE; Kimple ME; Breyer RM; Gannon M
    Mol Metab; 2017 Jun; 6(6):548-559. PubMed ID: 28580285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor.
    Gu X; Xu J; Zhu L; Bryson T; Yang XP; Peterson E; Harding P
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27502370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.